These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1887543)

  • 1. Multicenter study of superficial bladder cancer treated with intravesical bacillus Calmette-Guerin or adriamycin. Results of long-term follow-up.
    Khanna OP; Son DL; Son K; Mazer H; Read J; Nugent D; Cottone R; Heeg M; Rezvan M; Uhlman R
    Urology; 1991 Sep; 38(3):271-9. PubMed ID: 1887543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial bladder cancer treated by intravesical bacillus Calmette-Guerin or adriamycin: multicenter study interim report.
    Khanna OP; Son DL; Mazer H; Read J; Nugent D; Cottone R; Heeg M; Rezvan M; Viek N; Friedmann M
    Urology; 1987 Dec; 30(6):520-8. PubMed ID: 3318089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial bladder cancer treated with intravesical bacillus Calmette-Guérin or adriamycin: follow-up report.
    Khanna OP; Son DL; Mazer H; Read J; Nugent D; Cottone R; Heeg M; Rezvan M; Viek N; Uhlman R
    Urology; 1988 Apr; 31(4):287-93. PubMed ID: 3281363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter study of superficial bladder cancer treated with intravesical bacillus Calmette-Guérin or adriamycin.
    Khanna OP; Son DL; Mazer H; Read J; Nugent D; Cottone R; Heeg M; Rezvan M; Viek N; Uhlman R
    Urology; 1990 Feb; 35(2):101-8. PubMed ID: 2407020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor.
    Coplen DE; Marcus MD; Myers JA; Ratliff TL; Catalona WJ
    J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.
    Herr HW; Laudone VP; Badalament RA; Oettgen HF; Sogani PC; Freedman BD; Melamed MR; Whitmore WF
    J Clin Oncol; 1988 Sep; 6(9):1450-5. PubMed ID: 3418376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials.
    De Jager R; Guinan P; Lamm D; Khanna O; Brosman S; De Kernion J; Williams R; Richardson C; Muenz L; Reitsma D
    Urology; 1991 Dec; 38(6):507-13. PubMed ID: 1836081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
    Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
    J Urol; 1986 Oct; 136(4):820-4. PubMed ID: 3761438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.
    Kelley DR; Ratliff TL; Catalona WJ; Shapiro A; Lage JM; Bauer WC; Haaff EO; Dresner SM
    J Urol; 1985 Jul; 134(1):48-53. PubMed ID: 3892051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.
    Lamm DL; DeHaven JI; Shriver J; Sarosdy MF
    J Urol; 1991 Apr; 145(4):738-40. PubMed ID: 2005691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumors.
    Kavoussi LR; Torrence RJ; Gillen DP; Hudson MA; Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
    J Urol; 1988 May; 139(5):935-40. PubMed ID: 3361667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus Calmette-Guérin immunotherapy. Techniques and results.
    Brosman SA
    Urol Clin North Am; 1992 Aug; 19(3):557-64. PubMed ID: 1636239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial of bacillus Calmette-Guérin versus adriamycin in superficial bladder cancer: a South-West Oncology Group Study.
    Mori K; Lamm DL; Crawford ED
    Urol Int; 1986; 41(4):254-9. PubMed ID: 3538593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity.
    Lam JS; Benson MC; O'Donnell MA; Sawczuk A; Gavazzi A; Wechsler MH; Sawczuk IS
    Urol Oncol; 2003; 21(5):354-60. PubMed ID: 14670544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.
    Lamm DL; Blumenstein BA; Crawford ED; Montie JE; Scardino P; Grossman HB; Stanisic TH; Smith JA; Sullivan J; Sarosdy MF
    N Engl J Med; 1991 Oct; 325(17):1205-9. PubMed ID: 1922207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
    Herr HW; Badalament RA; Amato DA; Laudone VP; Fair WR; Whitmore WF
    J Urol; 1989 Jan; 141(1):22-9. PubMed ID: 2908949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study on prophylactic intravesical instillation of bacillus Calmette-Guerin (BCG) and adriamycin for superficial bladder cancers].
    Tachibana M; Jitsukawa S; Iigaya T; Shibayama T; Baba S; Deguchi N; Hata M; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1459-65. PubMed ID: 2601218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical bacillus Calmette-Guerin for superficial bladder cancer: experience with Danish 1331 strain.
    Kamat MR; Kulkarni JN; Tongaonkar HB; Dalal AV
    J Urol; 1994 Nov; 152(5 Pt 1):1424-8. PubMed ID: 7933175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.